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Abstract	  
Advances	   in	   flow	   cytometry	   bioinformatics	   have	   resulted	   in	   a	  wide	   variety	   of	   clustering,	   classification	  
and	   visualization	   techniques.	   To	   objectively	   evaluate	   the	   performance	   of	   such	   methods,	   common	  
benchmarks	  such	  as	  the	  FlowCAP	  initiative	  have	  proven	  to	  be	  of	  great	  value.	  In	  this	  work,	  we	  report	  on	  a	  
novel	  method,	  FloReMi,	  which	  was	  developed	  to	  tackle	  the	  most	  recent	  FlowCAP	  IV	  challenge.	  	  
This	   challenge	  was	   formulated	   as	   a	   survival	  modeling	   problem,	  where	   participants	  were	   expected	   to	  
design	  a	  model	  to	  predict	  the	  time	  until	  progression	  to	  AIDS	  for	  HIV	  patients.	  It	  is	  known	  that	  variability	  
in	  progression	  rate	  cannot	  be	  fully	  predicted	  by	  simple	  CD4+	  T	  cell	  counts.	  However,	   it	   is	  hypothesized	  
that	   the	   immunopathogenesis	   established	   early	   in	  HIV	   already	   indicates	   the	   course	  of	   future	  disease.	  
Adequately	  estimating	  the	  progression	  rate	  of	  HIV	  patients	  is	  crucial	  in	  their	  treatment.	  
Using	  an	  automated	  pipeline	  to	  preprocess	  the	  data,	  and	  subsequently	   identify	  and	  select	   informative	  
cell	   subsets,	  a	  survival	   regression	  method	  based	  on	  random	  survival	   forests	  was	  built,	  which	  obtained	  
the	  best	  results	  of	  all	  submitted	  approaches	  to	  the	  FlowCAP	  IV	  challenge.	  
	  Our	  pipeline	  is	  available	  at	  www.github.com/SofieVG/FloReMi.	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Introduction	  
Current	  cytometry	  techniques	  enable	  researchers	  to	  examine	  many	  markers	  at	  the	  same	  time.	  This	  gives	  
an	  unprecedented	  view	  on	  single	  cells,	  but	  also	  introduces	  several	  challenges.	  When	  many	  markers	  are	  
measured	  simultaneously,	  manual	  analysis	  becomes	  very	  time-­‐consuming	  and	  subjective.	  As	  it	  is	  
infeasible	  to	  manually	  analyze	  every	  possible	  cell	  population,	  only	  a	  subset	  of	  them	  is	  examined	  based	  
on	  previous	  experience.	  Several	  research	  groups	  have	  developed	  automatic	  clustering	  techniques	  to	  
assist	  the	  manual	  analysis,	  based	  on	  K-­‐means,	  mixture	  models,	  density	  estimation	  and	  more	  (e.g.	  1-­‐8).	  
However,	  the	  goal	  of	  an	  experiment	  is	  often	  not	  to	  identify	  all	  the	  cell	  types	  that	  are	  present,	  but	  to	  
identify	  those	  cell	  types	  that	  are	  indicative	  of	  some	  phenotype.	  In	  this	  case,	  machine	  learning	  techniques	  
can	  be	  used	  to	  identify	  subpopulations	  of	  cells	  in	  the	  dataset	  which	  can	  be	  used	  to	  predict	  the	  
phenotype	  of	  a	  patient.	  
A	  number	  of	  techniques	  have	  already	  been	  developed	  with	  this	  goal	  in	  mind.	  The	  FlowCAP	  II	  challenge	  
(9)	  was	  created	  to	  compare	  those	  techniques	  and	  provide	  some	  benchmark	  data.	  Several	  algorithms	  
were	  proposed,	  most	  of	  which	  combine	  an	  automatic	  clustering	  algorithm	  with	  a	  traditional	  
classification	  algorithm.	  Once	  the	  clusters	  are	  formed,	  features	  can	  be	  constructed	  and	  selected,	  which	  
can	  be	  used	  by	  traditional	  classification	  algorithms.	  One	  of	  the	  proposed	  algorithms,	  FlowType	  (10,11),	  
computes	  a	  threshold	  for	  every	  marker	  to	  express	  every	  possible	  subpopulation	  as	  a	  certain	  
combination	  of	  high/low	  marker	  values.	  Once	  all	  these	  subtypes	  are	  defined,	  statistical	  tests	  are	  
performed	  to	  identify	  those	  subtypes	  which	  contain	  information	  with	  regard	  to	  the	  class	  of	  the	  patients.	  
The	  Citrus	  algorithm	  (12)	  uses	  a	  hierarchical	  clustering	  algorithm	  to	  split	  the	  dataset	  into	  many	  possible	  
subdivisions.	  Afterwards,	  statistical	  tests	  are	  used	  to	  find	  significant	  differences	  between	  the	  data	  of	  two	  
classes.	  Classification	  algorithms	  trained	  with	  those	  features	  can	  be	  used	  to	  diagnose	  patients.	  	  
The	  majority	  of	  algorithms	  that	  were	  proposed	  in	  this	  field	  focus	  on	  classification	  tasks,	  where	  a	  class,	  
e.g.	  a	  disease	  status,	  is	  assigned	  to	  each	  patient.	  Less	  attention	  has	  been	  given	  to	  predict	  continuous	  
output	  variables	  based	  on	  flow	  cytometry	  data.	  To	  address	  this	  issue,	  the	  FlowCAP	  IV	  challenge	  was	  
proposed.	  The	  goal	  of	  the	  FlowCAP	  IV	  challenge	  was	  to	  predict	  the	  time	  until	  progression	  to	  AIDS	  for	  HIV	  
patients,	  a	  task	  which	  was	  manually	  studied	  in	  (13).	  In	  this	  paper,	  we	  present	  our	  approach	  for	  the	  
FlowCAP	  IV	  challenge,	  combining	  the	  flowType	  algorithm	  with	  a	  feature	  selection	  algorithm	  to	  identify	  
informative,	  non-­‐redundant	  features.	  We	  evaluated	  three	  survival	  time	  prediction	  algorithms	  using	  the	  
selected	  features,	  of	  which	  the	  random	  survival	  forest	  approach	  was	  the	  most	  successful,	  and	  obtained	  
the	  best	  predictive	  performance	  of	  all	  methods	  submitted	  to	  the	  challenge.	  
	   	  
Problem	  definition	  
The	  goal	  of	  the	  FlowCAP	  IV	  challenge	  was	  to	  predict	  the	  time	  until	  progression	  to	  AIDS	  for	  a	  test	  set	  of	  
192	  HIV	  patients,	  based	  on	  a	  training	  set	  of	  191	  patients.	  Patients	  were	  described	  by	  flow	  cytometry	  
data,	  from	  which	  features	  needed	  to	  be	  extracted	  to	  reach	  this	  goal.	  Identifying	  features	  that	  correlate	  
with	  the	  time	  until	  progression	  to	  AIDS,	  e.g.	  the	  size	  of	  a	  specific	  cell	  population	  in	  the	  dataset,	  was	  also	  
a	  goal	  of	  this	  challenge.	  
For	  each	  patient,	  a	  PBMC	  sample	  stimulated	  with	  HIV-­‐Gag	  peptides	  and	  an	  unstimulated	  control	  were	  
provided.	  The	  unstimulated	  sample	  gives	  an	  indication	  of	  the	  baseline	  state	  of	  the	  patient,	  whereas	  in	  
the	  stimulated	  sample	  immune	  response	  effects	  to	  the	  antigens	  might	  be	  observed.	  For	  each	  sample,	  
FSC-­‐A,	  FSC-­‐H,	  SSC-­‐A	  and	  13	  fluorescence	  channels	  were	  measured	  (indicating	  values	  for	  IFNγ,	  TNFα,	  
CD4,	  CD27,	  CD107-­‐A,	  CD154,	  CD3,	  CCR7,	  IL2,	  CD8,	  CD57,	  CD45RO	  and	  V-­‐Amine/CD14).	  Each	  patient	  of	  
the	  training	  set	  was	  also	  assigned	  a	  label	  indicating	  the	  observed	  clinical	  status	  (1	  =	  progression	  to	  AIDS	  
or	  death,	  0	  =	  no	  progression	  to	  AIDS	  or	  death)	  and,	  if	  there	  was	  progression	  to	  AIDS	  or	  death,	  the	  
survival	  time	  until	  the	  onset	  of	  AIDS.	  If	  there	  was	  no	  progression	  to	  AIDS,	  the	  time	  to	  the	  last	  evaluation	  
was	  given.	  It	  is	  important	  to	  notice	  that	  a	  label	  of	  zero	  does	  not	  mean	  that	  the	  patient	  did	  not	  develop	  
AIDS,	  but	  only	  that	  the	  patient	  at	  least	  did	  not	  develop	  AIDS	  until	  this	  last	  observation.	  This	  kind	  of	  data	  
is	  called	  ‘censored’	  information,	  because	  what	  happens	  after	  the	  last	  evaluation	  is	  unknown.	  From	  the	  
191	  patients	  in	  the	  training	  set,	  only	  34	  had	  actual	  events	  and	  157	  were	  censored.	  In	  the	  test	  set,	  45	  
patients	  had	  actual	  events	  and	  147	  were	  censored.	  This	  strongly	  complicated	  the	  computational	  
framework	  we	  had	  to	  use	  to	  build	  a	  model	  for	  this	  data.	  	  
The	  evaluation	  criterion	  for	  the	  challenge	  was	  based	  on	  the	  Cox	  proportional-­‐hazards	  model	  (14).	  This	  
model	  uses	  both	  event	  data	  and	  censored	  data	  to	  study	  the	  dependency	  of	  the	  survival	  times	  on	  
predictor	  variables	  and	  results	  in	  a	  p-­‐value	  indicating	  how	  well	  the	  variables	  fit	  the	  survival	  times.	  During	  
evaluation,	  the	  predicted	  survival	  times	  are	  used	  as	  predictor	  variable.	  
The	  FloReMi	  algorithm	  
The	  FloReMi	  approach	  consists	  of	  4	  steps.	  First	  the	  data	  is	  preprocessed,	  in	  order	  to	  remove	  noise.	  
Subsequently	  many	  features	  (i.e.	  properties	  pertaining	  to	  certain	  cell	  types)	  are	  extracted,	  after	  which	  a	  
selection	  of	  these	  features	  is	  made.	  Finally,	  we	  use	  the	  selected	  features	  in	  a	  regression	  model	  to	  predict	  
the	  time	  until	  the	  detection	  of	  AIDS	  for	  the	  patients.	  A	  schematic	  overview	  of	  our	  approach	  is	  given	  in	  
Figure	  1.	  Our	  method	  was	  developed	  specifically	  for	  the	  FlowCAP	  IV	  challenge,	  but	  our	  scripts	  are	  
available	  at	  www.github.com/SofieVG/FloReMi	  and	  can	  be	  adapted	  for	  other	  datasets.	  
Preprocessing	  
The	  preprocessing	  step	  was	  applied	  to	  each	  sample	  separately	  and	  consisted	  of	  6	  parts.	  	  
We	  started	  with	  a	  quality	  control	  step	  to	  detect	  problems	  during	  the	  acquisition	  of	  the	  sample	  by	  the	  
cytometer.	  This	  can	  be	  done	  by	  inspecting	  uniformity	  of	  the	  data	  with	  respect	  to	  the	  time	  parameter	  
(15).	  Therefore,	  we	  split	  the	  dataset	  in	  100	  equally	  sized	  intervals	  for	  the	  Time	  parameter.	  We	  calculated	  
the	  median	  FSC-­‐A	  value	  and	  the	  number	  of	  cells	  for	  each	  interval.	  Intervals	  were	  removed	  completely	  if	  
either	  their	  median	  FSC-­‐A	  value	  differed	  more	  than	  10,000	  from	  the	  interval	  right	  before	  or	  after	  it,	  or	  if	  
the	  number	  of	  cells	  in	  the	  interval	  was	  less	  than	  the	  median	  number	  of	  cells	  per	  interval	  minus	  two	  
standard	  deviations.	  These	  thresholds	  were	  defined	  after	  inspecting	  several	  problematic	  sample	  files.	  By	  
removing	  these	  intervals,	  we	  removed	  measurements	  with	  inconsistent	  values,	  caused	  by	  e.g.	  
disturbances	  of	  the	  flow	  stream,	  air	  bubbles	  or	  clogging	  of	  the	  flow	  cell.	  A	  similar	  technique	  has	  been	  
proposed	  by	  Fletez-­‐Brant,	  which	  is	  released	  in	  the	  flowClean	  R	  bioconductor	  library	  (16).	  On	  average,	  
5.30%	  (±3.60%)	  of	  the	  original	  cells	  were	  removed	  by	  this	  step	  
In	  the	  next	  preprocessing	  part,	  we	  removed	  all	  margin	  events.	  We	  defined	  a	  margin	  event	  as	  a	  
measurement	  which	  had	  either	  the	  minimum	  or	  maximum	  value	  in	  any	  dimension,	  or	  a	  measurement	  
which	  exceeded	  the	  ranges	  given	  in	  the	  description	  of	  the	  fcs-­‐files.	  Measurements	  which	  exceeded	  the	  
possible	  ranges	  were	  erroneous,	  and	  measurements	  which	  had	  the	  minimum	  or	  maximum	  value	  might	  
be	  saturated	  and	  out	  of	  the	  detection	  range	  of	  the	  cytometer,	  thus	  not	  representing	  the	  actual	  value	  
that	  should	  be	  measured.	  A	  similar	  technique	  is	  available	  in	  the	  flow	  cytometry	  module	  of	  GenePattern:	  
RemoveSaturatedFCSEvents	  (17).	  On	  average,	  2.72%(±3.83%)	  of	  the	  cells	  remaining	  after	  the	  first	  
preprocessing	  step	  were	  removed	  by	  this	  step.	  	  
Our	  third	  preprocessing	  step	  consisted	  of	  removing	  doublets.	  We	  computed	  the	  ratio	  r	  between	  FSC-­‐A	  
and	  FSC-­‐H,	  since	  for	  doublets,	  the	  area	  measured	  is	  larger	  in	  proportion	  to	  the	  height,	  because	  the	  signal	  
has	  the	  same	  strength	  but	  a	  longer	  duration	  in	  comparison	  with	  a	  single	  cell	  (18).	  We	  removed	  all	  cells	  
for	  which	  the	  ratio	  was	  larger	  than	  the	  median	  ratio	  of	  all	  cells	  plus	  two	  standard	  deviations,	  on	  average	  
4.45%(±1.25%)	  of	  the	  remaining	  cells	  after	  the	  first	  two	  preprocessing	  steps.	  𝑟!"##_!"_!""# ≤ 𝑚𝑒𝑑𝑖𝑎𝑛 𝑟!""_!"##$ +   2  𝑠𝑡𝑑𝑒𝑣(𝑟!""_!"##$)	  
The	  fourth	  and	  fifth	  steps	  in	  our	  preprocessing	  procedure	  were	  the	  traditional	  flow	  cytometry	  
preprocessing	  steps:	  compensation	  and	  transformation.	  We	  compensated	  the	  data	  using	  the	  spillover	  
matrix	  provided	  in	  the	  fcs-­‐files.	  We	  transformed	  the	  SSC	  channel	  and	  all	  color	  channels	  with	  the	  
logicleTransform()	  function	  from	  the	  R	  flowCore	  package	  (19),	  using	  all	  default	  settings.	  
Our	  final	  preprocessing	  step	  helped	  us	  to	  zoom	  in	  on	  the	  area	  of	  interest.	  We	  used	  an	  automatic	  gating	  
step	  to	  select	  only	  the	  alive	  T-­‐cells	  for	  further	  analysis.	  	  To	  do	  this,	  we	  used	  the	  R	  flowDensity	  package	  
(20).	  This	  package	  can	  automatically	  determine	  an	  optimal	  split	  in	  a	  single	  dimension	  of	  the	  dataset.	  We	  
used	  this	  to	  determine	  thresholds	  for	  both	  the	  V450-­‐A	  (Vivid/CD14)	  and	  R780-­‐A	  (CD3)	  channels.	  We	  
selected	  those	  cells	  that	  were	  low	  for	  V450-­‐A	  (alive,	  no	  macrophages	  or	  monocytes)	  and	  high	  for	  R780-­‐A	  
(T	  cells).	  
Feature	  extraction	  
Once	  the	  dataset	  was	  clean,	  we	  extracted	  features	  from	  it.	  By	  using	  automatic,	  unsupervised	  
techniques,	  we	  were	  able	  to	  examine	  a	  much	  larger	  scope	  of	  features	  than	  would	  be	  possible	  in	  any	  
manual	  analysis.	  The	  feature	  extraction	  part	  of	  the	  pipeline	  was	  executed	  on	  each	  sample	  separately.	  
First,	  we	  used	  the	  flowDensity	  algorithm	  (20)	  again	  to	  determine	  splits	  on	  ten	  dimensions:	  FSC-­‐A,	  SSC-­‐A,	  
G710-­‐A	  (CD4),	  G660-­‐A	  (CD27),	  G610-­‐A	  (CD107-­‐A),	  G560-­‐A,	  (CD154),	  R710-­‐A	  (CCR7),	  V800-­‐A	  (CD8),	  V585-­‐
A	  (CD57),	  V545-­‐A	  (CD45RO).	  This	  algorithm	  uses	  the	  density	  distribution	  of	  the	  cells	  to	  determine	  the	  
best	  possible	  split.	  If	  two	  peaks	  are	  detected,	  the	  minimum	  intersection	  point	  between	  the	  two	  peaks	  is	  
used.	  If	  there	  are	  more	  peaks,	  it	  takes	  into	  account	  the	  distance	  between	  the	  peaks	  and	  the	  height	  of	  
the	  valleys	  to	  determine	  which	  split	  gives	  the	  clearest	  cut.	  If	  no	  peaks	  are	  detected,	  it	  will	  use	  the	  95th	  
percentile	  to	  split	  on.	  We	  excluded	  the	  FSC-­‐H,	  V450-­‐A	  and	  R780-­‐A	  channels	  because	  they	  were	  dealt	  
with	  in	  the	  preprocessing	  step.	  We	  also	  excluded	  the	  intracellular	  markers	  IFNγ,	  IL2	  and	  TNFα,	  in	  order	  
to	  reduce	  computation	  time,	  even	  though	  this	  might	  lead	  to	  a	  loss	  of	  information.	  These	  intracellular	  
markers	  do	  not	  have	  two	  clear	  peaks	  typically,	  which	  makes	  it	  harder	  to	  get	  a	  good	  split	  automatically.	  
The	  second	  step	  in	  the	  feature	  extraction	  process	  was	  to	  define	  subsets,	  groups	  of	  cells	  which	  have	  the	  
same	  annotation	  of	  high/low	  marker	  intensities,	  based	  on	  the	  thresholds	  determined	  by	  the	  flowDensity	  
algorithm.	  We	  did	  this	  by	  using	  the	  flowType	  algorithm	  (10),	  examining	  every	  possible	  marker	  
combination	  for	  which	  the	  values	  are	  either	  high,	  low	  or	  neutral.	  By	  exploring	  all	  cell	  subsets	  with	  
combinations	  of	  high	  and	  low	  expression	  of	  the	  markers,	  we	  included	  many	  possible	  cell	  types	  that	  
might	  not	  be	  identified	  in	  a	  manual	  analysis.	  The	  flowType	  bioconductor	  package	  provides	  an	  efficient	  
implementation	  to	  assign	  cells	  to	  the	  subpopulations	  they	  belong	  to,	  using	  dynamic	  programming	  as	  an	  
optimization	  for	  the	  combinatorial	  problem	  (11).	  This	  led	  to	  310	  possibilities	  or	  59,049	  different	  subsets.	  
Once	  each	  subset	  was	  defined,	  we	  extracted	  features	  for	  each	  sample.	  For	  each	  subset,	  we	  computed	  
the	  percentage	  of	  cells	  and	  the	  mean	  fluorescence	  intensity	  for	  13	  markers	  (FSC-­‐A,	  SSC-­‐A,	  B515-­‐A	  (IFNγ),	  
G780-­‐A	  (TNFα),	  G710-­‐A	  (CD4),	  G660-­‐A	  (CD27),	  G610-­‐A	  (CD107-­‐A),	  G560-­‐A	  (CD154),	  R710-­‐A	  (CCR7),	  
R660-­‐A	  (IL2),	  V800-­‐A	  (CD8),	  V585-­‐A	  (CD57),	  V545-­‐A	  (CD45RO)).	  Because	  we	  included	  the	  intracellular	  
markers	  IFNγ,	  TNFα	  and	  IL2,	  their	  information	  might	  still	  be	  used	  even	  though	  they	  were	  not	  included	  in	  
the	  subset	  definitions.	  This	  leads	  to	  14	  features	  per	  subset.	  Because	  there	  was	  both	  stimulated	  and	  
unstimulated	  data	  present	  for	  each	  patient,	  we	  computed	  those	  fourteen	  features	  for	  all	  subsets	  for	  
both	  samples,	  and	  also	  the	  difference	  between	  the	  corresponding	  features	  from	  each	  sample.	  This	  
resulted	  in	  (310	  *	  14)	  *3	  or	  2,480,058	  features	  per	  patient.	  
Feature	  selection	  
Regression	  techniques	  are	  not	  able	  to	  efficiently	  handle	  such	  a	  huge	  amount	  of	  features.	  To	  solve	  this	  
problem,	  the	  third	  step	  of	  our	  pipeline	  was	  a	  feature	  selection	  step.	  In	  this	  step,	  we	  wanted	  to	  select	  
those	  features	  which	  have	  a	  high	  correlation	  with	  the	  survival	  time.	  However,	  because	  of	  the	  high	  
percentage	  of	  censored	  values,	  we	  could	  not	  simply	  use	  the	  Pearson	  correlation	  to	  measure	  the	  
importance	  of	  a	  feature.	  Therefore,	  we	  made	  use	  of	  the	  Cox	  proportional-­‐hazards	  model.	  
We	  used	  the	  whole	  training	  dataset	  to	  compute	  a	  Cox	  proportional-­‐hazards	  model	  for	  each	  feature	  
separately.	  This	  model	  returned	  a	  p-­‐value	  and	  a	  concordance	  index,	  which	  indicated	  how	  strongly	  the	  
feature	  itself	  corresponded	  with	  the	  actual	  survival	  times	  of	  the	  patients.	  We	  ranked	  the	  features	  by	  the	  
p-­‐values	  from	  their	  corresponding	  models.	  
Strongly	  correlated	  features	  will	  have	  a	  negative	  impact	  on	  a	  Cox	  proportional-­‐hazards	  model.	  In	  order	  
to	  minimize	  the	  redundancy	  between	  the	  selected	  features,	  we	  therefore	  did	  not	  simply	  pick	  the	  first	  k	  
features	  from	  the	  resulting	  list.	  Instead,	  we	  started	  with	  the	  two	  features	  with	  the	  lowest	  p-­‐values,	  and	  
then	  iteratively	  added	  new	  features	  when	  the	  pairwise	  Pearson	  correlation	  between	  the	  previously	  
selected	  features	  and	  the	  new	  candidate	  feature	  was	  low	  enough.	  We	  chose	  a	  threshold	  of	  0.2,	  to	  make	  
sure	  that	  no	  strong	  correlations	  exist	  between	  the	  selected	  features.	  When	  using	  different	  thresholds,	  
such	  as	  0.15	  or	  0.25,	  different	  features	  were	  selected	  (Supplementary	  Tables	  1	  and	  2).	  However,	  final	  
prediction	  results	  were	  very	  similar	  (Supplementary	  Table	  3).	  	  
Survival	  time	  prediction	  
The	  selected	  features	  were	  used	  to	  predict	  the	  actual	  survival	  time	  of	  the	  patients:	  we	  converted	  the	  
original	  training	  and	  test	  datasets	  consisting	  of	  all	  fcs	  files	  to	  two	  matrices	  in	  which	  the	  rows	  
represented	  the	  patients	  and	  the	  columns	  the	  selected	  features.	  We	  evaluated	  three	  different	  
regression	  techniques	  to	  reach	  this	  goal:	  Cox	  proportional-­‐hazards	  regression	  (14),	  random	  survival	  
forests	  (21)	  and	  additive	  hazards	  regression	  (22).	  For	  each	  technique,	  we	  performed	  leave-­‐one-­‐out	  cross	  
validation	  on	  the	  training	  dataset	  to	  evaluate	  our	  results,	  and	  built	  a	  final	  model	  using	  the	  whole	  training	  
dataset	  to	  make	  predictions	  for	  the	  test	  set.	  	  
Next	  to	  the	  p-­‐value	  of	  the	  Cox	  proportional-­‐hazards	  model,	  we	  also	  used	  the	  concordance	  index	  (23)	  to	  
evaluate	  our	  results.	  To	  compute	  the	  concordance	  index,	  all	  pairs	  of	  comparable	  patients	  are	  checked.	  A	  
pair	  is	  comparable	  when	  either	  both	  patients	  have	  progressed	  to	  AIDS,	  or	  one	  patient	  has	  progressed	  to	  
AIDS	  in	  a	  shorter	  time	  than	  the	  time	  to	  the	  last	  evaluation	  of	  the	  censored	  patient.	  The	  concordance	  
index	  is	  the	  percentage	  of	  pairs	  for	  which	  the	  predicted	  survival	  time	  order	  corresponds	  to	  the	  actual	  
order.	  This	  means	  a	  random	  assignment	  will	  lead	  to	  a	  score	  of	  about	  0.5,	  whereas	  a	  perfect	  assignment	  
will	  give	  a	  score	  of	  1	  and	  a	  reverse	  assignment	  will	  give	  a	  score	  of	  0.	  
The	  first	  technique	  we	  executed	  was	  the	  Cox	  proportional-­‐hazards	  regression.	  We	  built	  this	  model	  with	  
an	  increasing	  number	  of	  uncorrelated	  features	  until	  the	  corresponding	  concordance	  index	  did	  no	  longer	  
improve,	  as	  illustrated	  in	  Figure	  2.	  This	  resulted	  in	  a	  feature	  set	  of	  13	  features,	  as	  presented	  in	  Table	  3.	  It	  
might	  be	  surprising	  that	  no	  TNFα	  related	  features	  are	  included	  in	  this	  set.	  However,	  notice	  that	  we	  start	  
with	  the	  best	  scored	  features	  and	  only	  add	  those	  with	  almost	  no	  correlation	  (<0.2)	  with	  the	  features	  
already	  selected.	  Some	  other	  features	  with	  better	  p-­‐values	  and	  a	  correlation	  greater	  than	  0.2	  with	  the	  
TNFα	  related	  features	  are	  added	  first	  to	  the	  selection,	  which	  results	  in	  no	  TNFα	  related	  features	  in	  our	  
end	  selection.	  E.g.	  our	  third	  selected	  feature,	  the	  difference	  of	  the	  CD107a	  MFI	  values	  of	  the	  SSC-­‐	  CD27+	  
CD107a+	  CD154-­‐	  CD8+	  CD45RO-­‐	  cell	  subset,	  has	  a	  correlation	  of	  0.25	  with	  the	  best	  ranking	  TNFα	  related	  
feature	  (the	  TNFα	  MFI	  of	  the	  stimulated	  sample	  of	  the	  SSC+	  CD4-­‐	  CD27+	  CD107a-­‐	  CCR7-­‐	  CD57-­‐	  CD45RO-­‐	  
cell	  subset).	  
The	  second	  technique	  we	  evaluated	  was	  the	  random	  survival	  forest,	  as	  implemented	  by	  the	  
randomForestSRC	  package(24).	  The	  random	  survival	  forest	  uses	  survival	  trees,	  in	  which	  each	  split	  is	  
made	  in	  such	  a	  way	  that	  it	  maximizes	  the	  survival	  difference	  between	  the	  daughter	  nodes.	  It	  explicitly	  
takes	  censored	  data	  into	  account.	  We	  used	  the	  same	  13	  features	  as	  we	  had	  used	  with	  the	  Cox	  
proportional-­‐hazards	  regression	  and	  trained	  a	  forest	  with	  500	  regression	  trees.	  This	  model	  returns	  the	  
mortality,	  rather	  than	  the	  survival	  time,	  of	  patients.	  To	  report	  our	  results,	  we	  scaled	  the	  values	  between	  
0	  and	  1	  and	  reversed	  them,	  because	  a	  higher	  mortality	  corresponds	  with	  a	  shorter	  time	  until	  
progression	  to	  AIDS	  or	  death.	  
Finally,	  we	  also	  used	  regularization	  for	  semiparametric	  additive	  hazards	  regression,	  as	  implemented	  by	  
the	  ahaz	  package	  (25).	  This	  method	  is	  a	  regularized	  version	  of	  the	  standard	  hazards	  model,	  and	  thus	  
should	  inherently	  perform	  feature	  selection	  (similar	  to	  standard	  Lasso	  or	  Elastic	  net	  for	  the	  traditional	  
regression	  setting).	  With	  the	  best	  100	  features	  from	  the	  feature	  selection	  step,	  a	  model	  was	  trained	  by	  
performing	  a	  5-­‐fold	  internal	  cross	  validation	  on	  the	  training	  set	  to	  find	  the	  optimal	  parameter	  settings.	  
These	  parameter	  settings	  were	  then	  used	  to	  train	  a	  final	  model.	  We	  also	  tested	  the	  model	  with	  the	  best	  
80	  or	  200	  features,	  but	  the	  results	  were	  very	  similar	  (Supplementary	  Table	  4).	  
	   	  
Results	  and	  Discussion	  
During	  the	  challenge,	  the	  correct	  results	  for	  the	  test	  dataset	  were	  obviously	  hidden	  for	  the	  participants.	  
Therefore,	  we	  performed	  leave-­‐one-­‐out	  cross	  validation	  to	  evaluate	  our	  techniques.	  We	  present	  the	  
results	  of	  our	  cross-­‐validation	  in	  Table	  1.	  Since	  all	  three	  algorithms	  performed	  well	  for	  cross-­‐validation,	  
we	  submitted	  all	  three	  versions	  to	  the	  FlowCAP	  IV	  challenge.	  
Once	  the	  challenge	  was	  finished,	  the	  correct	  results	  for	  the	  test	  dataset	  were	  communicated.	  We	  
present	  our	  results	  in	  Table	  2.	  Surprisingly,	  the	  results	  of	  the	  three	  algorithms	  differed	  greatly	  on	  the	  
test	  dataset.	  Both	  the	  Cox	  proportional-­‐hazards	  regression	  and	  the	  additive	  hazards	  regression	  
algorithm	  performed	  very	  badly.	  They	  have	  concordance	  scores	  around	  0.5,	  which	  corresponds	  with	  a	  
random	  assignment.	  However,	  the	  random	  survival	  forest	  algorithm	  did	  perform	  quite	  well	  on	  the	  test	  
set,	  and	  actually	  obtained	  the	  best	  result	  of	  all	  participants	  of	  the	  FlowCAP	  IV	  challenge.	  Seven	  other	  
groups	  participated,	  using	  a	  whole	  range	  of	  methods:	  one	  based	  on	  Boruta	  and	  FlowFP	  (26),	  one	  based	  
on	  SPADE	  (27),	  one	  using	  a	  regression	  tree	  on	  a	  target	  vector	  combining	  clinical	  diagnosis	  and	  survival	  
time,	  gEM/GANN	  (28),	  another	  also	  based	  on	  flowDensity	  and	  flowType,	  but	  combined	  with	  
RchyOptimyx	  (11)	  and	  two	  other	  methods	  of	  which	  the	  strategy	  is	  not	  known	  to	  us	  at	  the	  moment.	  
Our	  results	  are	  illustrated	  in	  Figure	  3,	  where	  the	  real	  survival	  times	  are	  compared	  to	  the	  predicted	  
scores.	  For	  the	  training	  dataset,	  a	  clear	  correlation	  between	  the	  predictions	  and	  the	  real	  survival	  times	  is	  
present	  for	  all	  algorithms:	  the	  line	  has	  an	  upward	  slope	  and	  if	  it	  takes	  more	  time	  for	  an	  event	  to	  occur,	  
the	  patient	  will	  get	  a	  higher	  score.	  Notice	  that	  the	  steepness	  of	  the	  curve	  is	  not	  informative	  because	  we	  
rescaled	  all	  our	  results	  between	  0	  and	  1	  at	  the	  end	  of	  the	  prediction	  process.	  However,	  on	  the	  test	  set,	  
we	  see	  the	  same	  results	  as	  described	  above:	  there	  is	  no	  correlation	  at	  all	  for	  the	  results	  of	  the	  Cox	  
proportional-­‐hazards	  model	  and	  the	  additive	  hazards	  model.	  For	  the	  random	  survival	  forest,	  there	  is	  
some	  correlation,	  but	  the	  data	  spread	  is	  much	  wider:	  many	  patients	  get	  a	  score	  corresponding	  to	  their	  
survival	  time,	  but	  several	  patients	  get	  a	  score	  that	  is	  too	  high.	  We	  want	  to	  stress	  the	  importance	  of	  our	  
feature	  selection	  step	  here.	  If	  we	  pick	  the	  1000	  features	  with	  the	  best	  scores,	  without	  our	  redundancy-­‐
based	  selection	  process,	  the	  concordance	  index	  of	  the	  Random	  Survival	  Forest	  model	  drops	  to	  0.512	  for	  
the	  test	  set.	  
Because	  the	  Cox	  proportional-­‐hazards	  regression	  and	  the	  additive	  hazards	  regression	  performed	  well	  on	  
the	  training	  data,	  but	  badly	  on	  the	  test	  data,	  we	  suspect	  overfitting	  might	  be	  the	  problem.	  The	  models	  
do	  not	  generalize	  to	  new	  data,	  which	  indicates	  they	  are	  capturing	  too	  much	  specific	  details	  of	  the	  
training	  set.	  When	  a	  model	  is	  used	  for	  diagnosis,	  the	  main	  goal	  is	  to	  make	  predictions	  for	  new	  samples,	  
which	  are	  not	  available	  at	  the	  time	  of	  building	  the	  model.	  However,	  when	  overfitting	  on	  the	  training	  
dataset,	  the	  model	  uses	  very	  specific	  details	  of	  the	  training	  set	  which	  are	  not	  applicable	  to	  the	  whole	  
population	  of	  interest.	  As	  such,	  it	  will	  fail	  to	  make	  good	  predictions	  for	  new	  samples,	  which	  is	  the	  case	  
here	  in	  the	  validation	  on	  the	  test	  set.	  In	  the	  prediction	  step	  we	  performed	  leave-­‐one-­‐out	  cross-­‐
validation,	  but	  in	  the	  feature	  selection	  step,	  the	  whole	  training	  dataset	  was	  used	  to	  score	  the	  features.	  
The	  random	  forest	  approach	  uses	  the	  same	  features,	  but	  might	  be	  more	  robust	  against	  overfitting	  
because	  of	  the	  ensemble	  approach.	  Intuitively,	  random	  forests	  may	  also	  perform	  better	  because	  they	  
are	  a	  non-­‐linear	  model	  and,	  as	  such,	  they	  are	  better	  able	  to	  model	  interactions	  between	  features.	  
All	  our	  results	  were	  generated	  on	  a	  single	  computing	  node.	  The	  feature	  extraction	  step	  took	  about	  3	  
days,	  while	  all	  other	  parts	  took	  only	  a	  couple	  of	  minutes,	  so	  this	  part	  is	  clearly	  the	  bottleneck	  for	  a	  faster	  
workflow.	  However,	  it	  could	  be	  easily	  parallelized,	  because	  the	  preprocessing	  and	  feature	  extraction	  
happens	  independently	  for	  each	  sample.	  When	  a	  computing	  cluster	  is	  available,	  this	  could	  strongly	  
reduce	  running	  time.	  
The	  goal	  of	  the	  challenge	  was	  not	  only	  to	  predict	  the	  survival	  times,	  but	  also	  to	  identify	  features	  that	  
might	  be	  useful	  for	  the	  diagnosis	  of	  HIV	  patients.	  In	  Table	  3,	  we	  present	  the	  13	  features	  that	  were	  used	  
for	  the	  Cox	  proportional-­‐hazards	  regression	  model	  and	  the	  random	  survival	  forest.	  We	  notice	  that	  
features	  from	  the	  unstimulated	  sample,	  from	  the	  stimulated	  sample	  and	  from	  the	  differences	  between	  
the	  two	  are	  selected,	  indicating	  that	  it	  was	  essential	  to	  use	  both	  samples	  in	  the	  analysis.	  The	  chosen	  
features	  contain	  not	  only	  the	  percentage	  of	  cells	  for	  specific	  subpopulations,	  but	  also	  the	  mean	  
fluorescence	  intensities	  for	  several	  markers.	  These	  features	  imply	  that	  a	  shift	  in	  abundance	  of	  markers	  
might	  happen	  for	  certain	  cell	  types.	  
It	  is	  important	  to	  keep	  in	  mind	  that	  all	  population	  boundaries	  are	  automatically	  determined	  and	  might	  
not	  exactly	  correspond	  with	  a	  manual	  gating	  of	  the	  data.	  Even	  if	  this	  would	  be	  the	  case,	  it	  is	  still	  quite	  
hard	  to	  interpret	  the	  features	  in	  a	  biological	  way.	  For	  example,	  the	  best	  feature	  (see	  top	  row	  in	  Table	  3)	  
is	  negative	  for	  all	  five	  specified	  markers	  and	  neutral	  for	  the	  others,	  while	  traditionally	  cell	  types	  are	  
defined	  in	  a	  positive	  way,	  by	  having	  a	  certain	  marker	  present.	  In	  general,	  every	  marker	  except	  CD4	  is	  
used	  as	  least	  as	  much	  as	  a	  negative	  marker	  than	  as	  a	  positive	  marker.	  This	  might	  indicate	  that	  a	  certain	  
cell	  type	  which	  does	  not	  express	  the	  stained	  markers	  could	  correspond	  well	  with	  the	  progression	  rate.	  It	  
is	  likely	  that	  our	  best	  feature	  corresponds	  with	  effector	  CD8+	  cells	  (29),	  but	  future	  research	  will	  be	  
necessary	  to	  interpret	  all	  the	  features	  correctly	  and	  gain	  more	  insight	  in	  the	  process	  from	  HIV	  to	  AIDS.	   	  
Conclusion	  
In	  this	  paper	  we	  presented	  the	  FloReMi	  approach	  for	  the	  FlowCAP	  IV	  challenge,	  in	  which	  we	  analyzed	  
flow	  cytometry	  data	  to	  predict	  survival	  times	  of	  HIV	  patients.	  We	  first	  thoroughly	  cleaned	  the	  data	  and	  
extracted	  more	  than	  2.4	  million	  features	  for	  each	  patient.	  A	  feature	  selection	  step	  selected	  relevant	  
features	  with	  minimal	  redundancy.	  
We	  evaluated	  three	  different	  survival	  time	  prediction	  methods,	  of	  which	  only	  the	  random	  survival	  forest	  
method	  performed	  well.	  This	  method	  obtained	  the	  best	  results	  in	  the	  FlowCAP	  IV	  challenge	  by	  using	  a	  
selection	  of	  13	  features.	  	  
It	  is	  interesting	  to	  notice	  that	  the	  four	  steps	  of	  the	  FloReMi	  pipeline	  work	  independently	  of	  each	  other.	  A	  
new	  preprocessing	  step,	  feature	  extraction	  method	  or	  feature	  selection	  method	  could	  be	  plugged	  in	  
without	  any	  problems,	  and	  several	  prediction	  algorithms	  can	  be	  used,	  as	  we	  did	  in	  this	  paper.	  This	  
leaves	  much	  room	  for	  improvement	  for	  each	  of	  the	  steps	  separately	  and	  poses	  finding	  an	  optimal	  
combination	  as	  a	  new	  goal.	  
In	  future	  work,	  we	  will	  investigate	  the	  optimization	  of	  each	  step	  of	  the	  pipeline.	  Other	  score	  metrics	  
could	  be	  used	  to	  rank	  the	  features,	  although	  they	  do	  have	  to	  take	  censored	  data	  into	  account.	  The	  
Random	  Survival	  Forest	  computes	  a	  mortality	  score	  instead	  of	  a	  survival	  time,	  which	  are	  closely	  related	  
but	  not	  exactly	  the	  same.	  Other	  regression	  techniques	  which	  can	  handle	  censored	  data	  might	  work	  
better.	  
Once	  the	  algorithm	  is	  optimized,	  more	  research	  could	  be	  done	  to	  interpret	  the	  resulting	  features.	  
Biological	  validation	  might	  be	  necessary	  and	  the	  results	  we	  present	  can	  be	  seen	  as	  a	  starting	  point	  for	  
other	  research	  projects	  to	  unravel	  the	  details	  of	  HIV.	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Tables	  
	  





p-­‐value	   0.000	   0.000	   0.000	  
Concordance	  index	   0.891	   0.852	   0.815	  
	  
Table	  1:	  Results	  of	  the	  three	  regression	  models	  on	  leave-­‐one-­‐out	  cross	  validation.	  All	  methods	  
performed	  well	  during	  cross	  validation.	  
Final	  results	  
Cox	  Proportional-­‐Hazards	   Random	  Survival	  Forests	   Additive	  Hazards	  
All	  data	   Train	   Test	   All	  data	   Train	   Test	   All	  data	   Train	   Test	  
p-­‐value	   0.000	   0.000	   0.733	   0.000	   0.000	   0.002	   0.000	   0.000	   0.782	  
Concordance	  
index	  
0.662	   0.932	   0.459	   0.813	   0.976	   0.672	   0.635	   0.875	   0.527	  
	  
Table	  2:	  Final	  results	  of	  the	  three	  regression	  models	  on	  the	  FlowCAP	  IV	  challenge.	  Only	  the	  Random	  
Survival	  Forest	  obtains	  good	  results	  for	  the	  test	  set,	  which	  might	  indicate	  overfitting	  for	  the	  other	  
models.	  
Feature	   Sample	   Subset	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD107a-­‐	  CD154-­‐	  CD45RO-­‐	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD154-­‐	  CD8+	  
CD107a	  MFI	   Difference	   SSC-­‐	  CD27+	  CD107a+	  CD154-­‐	  CD8+	  CD45RO-­‐	  
Percentage	  of	  cells	   Difference	   FSC-­‐	  CD4+	  CD107a-­‐	  CD154-­‐	  CCR7+	  CD8+	  CD57-­‐	  CD45RO-­‐	  
CD4	  MFI	   Unstimulated	   FSC-­‐	  CCR7-­‐	  CD57-­‐	  CD45RO-­‐	  
IL2	  MFI	   Difference	   FSC+	  SSC+	  CD107a-­‐	  CCR7-­‐	  CD8-­‐	  
IL2	  MFI	   Unstimulated	   FSC-­‐	  SSC-­‐	  CD4+	  CD27-­‐	  CD107a+	  CD8-­‐	  CD57-­‐	  
IFNγ	  MFI	   Difference	   CD27-­‐	  CD107a-­‐	  CD154+	  CCR7-­‐	  CD57+	  CD45RO+	  
CD57	  MFI	   Unstimulated	   SSC-­‐	  CD4+	  CD27-­‐	  CD107a-­‐	  CCR7-­‐	  CD8+	  
Percentage	  of	  cells	   Stimulated	   FSC-­‐	  CD4-­‐	  CD27-­‐	  CD154-­‐	  CCR7+	  CD8-­‐	  CD57-­‐	  
Percentage	  of	  cells	   Stimulated	   FSC+	  SSC+	  CD4-­‐	  CD154-­‐	  CCR7+	  CD8-­‐	  CD57-­‐	  CD45RO+	  
CD8	  MFI	   Difference	   CD4+	  CD27-­‐	  CD107a+	  CCR7-­‐	  CD8-­‐	  CD57-­‐	  
CD8	  MFI	   Difference	   SSC-­‐	  CD154+	  CD57+	  CD45RO-­‐	  
	  
Table	  3:	  Overview	  of	  the	  top	  13	  features	  of	  the	  feature	  selection	  step,	  which	  were	  used	  by	  the	  Cox	  
proportional-­‐hazards	  model	  and	  the	  random	  survival	  forest.	  Both	  features	  from	  the	  stimulated	  and	  the	  
unstimulated	  samples	  are	  used,	  as	  well	  as	  comparisons	  between	  the	  two.	  Both	  percentages	  of	  cells	  and	  
mean	  fluorescence	  intensities	  (MFI)	  of	  specific	  markers	  are	  used.	  It	  is	  remarkable	  that	  mainly	  a	  negative	  




Figure	  1:	  Overview	  of	  the	  four	  steps	  of	  the	  FloReMi	  algorithm:	  preprocessing,	  feature	  extraction,	  feature	  
selection	  and	  survival	  time	  prediction.	  (i)	  During	  the	  preprocessing,	  6	  steps	  are	  executed:	  problems	  
during	  measurement	  are	  detected,	  margin	  events	  and	  doublets	  are	  removed,	  the	  data	  is	  compensated	  
and	  logicle-­‐transformed	  and	  alive	  T	  cells	  are	  selected.	  (ii)	  During	  feature	  extraction,	  310	  subsets	  are	  
identified.	  Each	  subset	  can	  be	  described	  by	  the	  percentage	  of	  cells	  present	  in	  the	  subset	  and	  13	  MFI	  
values.	  All	  these	  features	  are	  computed	  for	  the	  stimulated	  and	  the	  unstimulated	  data,	  and	  then	  also	  the	  
differences	  between	  the	  features	  for	  the	  two	  data	  sets	  are	  added.	  This	  results	  in	  2,480,058	  features	  per	  
patient.	  (iii)	  During	  feature	  selection,	  a	  Cox	  proportional-­‐hazards	  model	  is	  built	  for	  each	  feature	  
separately,	  and	  the	  features	  are	  sorted	  by	  p-­‐value	  (lowest	  first).	  For	  the	  actual	  selection,	  we	  start	  with	  
the	  two	  first	  features	  and	  only	  add	  those	  which	  have	  pairwise	  correlation	  lower	  than	  0.2	  to	  all	  other	  
selected	  features.	  (iv)	  In	  the	  final	  step,	  we	  evaluated	  three	  different	  survival	  time	  prediction	  models:	  the	  




Figure	  2:	  Concordance	  indices	  used	  to	  choose	  our	  feature	  selection	  cut-­‐off.	  Using	  13	  features,	  the	  
concordance	  index	  was	  optimal	  for	  the	  training	  set.	  
	  
	  Figure	  3:	  Results	  of	  the	  different	  models	  on	  training	  and	  test	  set.	  The	  prediction	  scores	  of	  the	  models	  
have	  all	  been	  rescaled	  between	  0	  and	  1	  to	  provide	  a	  ranking.	  On	  the	  training	  set,	  all	  models	  have	  a	  
correlation	  with	  the	  real	  survival	  times,	  as	  indicated	  by	  the	  regression	  line	  through	  the	  patients	  with	  
events.	  However,	  on	  the	  test	  set,	  only	  the	  random	  survival	  forest	  has	  a	  correlation.	  This	  indicates	  that	  
the	  other	  models	  overfit	  on	  the	  training	  set.	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Feature	   Sample	   Subset	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD107a-­‐	  CD154-­‐	  CD45RO-­‐	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD154-­‐	  CD8+	  
Percentage	  of	  cells	   Difference	   FSC-­‐	  CD4+	  CD107a-­‐	  CD154-­‐	  CCR7+	  CD8+	  CD57-­‐	  CD45RO-­‐	  
IFNγ	  MFI	   Stimulated	   FSC-­‐	  CD4+	  CD107a+	  CD45RO-­‐	  
IL2	  MFI	   Stimulated	   SSC-­‐	  CD107+	  CCR7-­‐	  CD8-­‐	  CD45RO-­‐	  
IL2	  MFI	   Difference	   FSC+	  SSC+	  CD107a-­‐	  CCR7-­‐	  CD8-­‐	  
Percentage	  of	  cells	   Stimulated	   SSC+	  CD4-­‐	  CD27-­‐	  CD107a+	  CD154-­‐	  CCR7+	  CD57-­‐	  
CD8	  MFI	   Difference	   CD4+	  CD27-­‐	  CD107a+	  CCR7-­‐	  CD8-­‐	  CD57-­‐	  
CD8	  MFI	   Difference	   SSC-­‐	  CD154+	  CD57+	  CD45RO-­‐	  
	  
Supplementary	  Table	  1:	  Overview	  of	  the	  top	  features	  selected	  with	  a	  correlation	  threshold	  of	  0.15	  
Feature	   Sample	   Subset	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD107a-­‐	  CD154-­‐	  CD45RO-­‐	  
Percentage	  of	  cells	   Unstimulated	   CD4-­‐	  CD27-­‐	  CD154-­‐	  CD8+	  
CD4a	  MFI	   Difference	   CD4+	  CD27+	  CCR7-­‐	  CD8-­‐	  CD45RO+	  
CD107a	  MFI	   Difference	   SSC-­‐	  CD27+	  CD107a+	  CD154-­‐	  CD8+	  CD45RO-­‐	  
CCR7	  MFI	   Unstimulated	   FSC-­‐	  CD4-­‐	  CD57-­‐	  CD45RO-­‐	  
CD4	  MFI	   Difference	   FSC+	  CD4-­‐	  CD27-­‐	  CD57+	  
IL2	  MFI	   Difference	   SSC-­‐	  CD27+	  CCR7-­‐	  CD57+	  CD45RO+	  
IL2	  MFI	   Difference	   FSC+	  SSC+	  CD107a-­‐	  CCR7-­‐	  CD8-­‐	  
Percentage	  of	  cells	   Stimulated	   FSC-­‐	  SSC-­‐	  CD4-­‐	  CD107a-­‐	  CCR7-­‐	  CD57-­‐	  
Percentage	  of	  cells	   Difference	   FSC-­‐	  SSC+	  CD4-­‐	  CD27-­‐	  CD154-­‐	  CD57-­‐	  
IFNγ	  MFI	   Difference	   CD27-­‐	  CD107a-­‐	  CD154+	  CCR7-­‐	  CD57+	  CD45RO+	  
CD8	  MFI	   Difference	   SSC-­‐	  CD4+	  CD107a+	  CD8-­‐	  CD57-­‐	  
Percentage	  of	  cells	   Stimulated	   FSC-­‐	  CD4-­‐	  CD27-­‐	  CD107a+	  CD154-­‐	  CCR7+	  CD8-­‐	  CD57-­‐	  
	  
Supplementary	  Table	  2:	  Overview	  of	  the	  top	  features	  selected	  with	  a	  correlation	  threshold	  of	  0.25	  
	  
Threshold	  	  0.15	  
Cox	  Proportional-­‐Hazards	  	   Random	  Survival	  Forest	  
All	  data	   Train	   Test	   All	  data	   Train	   Test	  
p-­‐value	   0.000	   0.000	   0.737	   0.000	   0.000	   0.042	  
Concordance	  index	   0.632	   0.906	   0.429	   0.763	   0.973	   0.572	  
	  
Threshold	  	  0.25	  
Cox	  Proportional-­‐Hazards	  	   Random	  Survival	  Forest	  
All	  data	   Train	   Test	   All	  data	   Train	   Test	  
p-­‐value	   0.000	   0.000	   0.634	   0.000	   0.000	   0.015	  
Concordance	  index	   0.676	   0.899	   0.517	   0.828	   0.973	   0.707	  
	  
Supplementary	  Table	  3:	  The	  final	  prediction	  results	  are	  very	  similar	  for	  slight	  variations	  in	  the	  correlation	  









All	  data	   Train	   Test	   All	  data	   Train	   Test	   All	  data	   Train	   Test	  
p-­‐value	   0.000	   0.000	   0.832	   0.000	   0.000	   0.782	   0.000	   0.000	   0.578	  
Concordance	  
index	  
0.629	   0.871	   0.540	   0.635	   0.875	   0.527	   0.645	   0.878	   0.478	  
	  
Supplementary	  Table	  4:	  The	  additive	  hazards	  method	  is	  quite	  robust	  to	  changes	  in	  the	  number	  of	  input	  
features,	  because	  it	  includes	  regularization	  in	  the	  model	  building.	  
	  
